Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Other Non Operating Income (2016 - 2025)

Cytosorbents (CTSO) has disclosed Other Non Operating Income for 14 consecutive years, with -$64000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 102.41% year-over-year to -$64000.0, compared with a TTM value of $4.2 million through Sep 2025, up 25.55%, and an annual FY2024 reading of -$4.2 million, down 316.73% over the prior year.
  • Other Non Operating Income was -$64000.0 for Q3 2025 at Cytosorbents, down from $6.2 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $6.2 million in Q2 2025 and bottomed at -$4.9 million in Q4 2024.
  • Average Other Non Operating Income over 5 years is $96139.9, with a median of -$493488.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income tumbled 1177.61% in 2022, then surged 1235.66% in 2025.
  • Year by year, Other Non Operating Income stood at -$493488.0 in 2021, then soared by 1015.53% to $4.5 million in 2022, then crashed by 40.61% to $2.7 million in 2023, then plummeted by 282.79% to -$4.9 million in 2024, then surged by 98.7% to -$64000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CTSO at -$64000.0 in Q3 2025, $6.2 million in Q2 2025, and $3.0 million in Q1 2025.